At the time of writing, DarioHealth Corp [DRIO] stock is trading at $0.74, up 13.86%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DRIO shares have lost -1.32% over the last week, with a monthly amount drifted -6.32%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
DarioHealth Corp [NASDAQ: DRIO] stock has seen the most recent analyst activity on May 13, 2022, when Alliance Global Partners upgraded its rating to a Buy but kept the price target unchanged to $8.75 for it. Previously, Cowen started tracking the stock with Outperform rating on April 22, 2021, and set its price target to $31. On March 23, 2021, Stifel initiated with a Buy rating and assigned a price target of $30 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $35 on February 25, 2021. Alliance Global Partners downgraded its rating to a Neutral and raised its price target to $22.25 on February 01, 2021. Aegis Capital started tracking with a Buy rating for this stock on August 17, 2020, and assigned it a price target of $25. In a note dated August 29, 2017, Aegis Capital initiated an Buy rating and provided a target price of $3.50 on this stock.
For the past year, the stock price of DarioHealth Corp fluctuated between $0.65 and $2.60. Currently, Wall Street analysts expect the stock to reach $10.75 within the next 12 months. DarioHealth Corp [NASDAQ: DRIO] shares were valued at $0.74 at the most recent close of the market. An investor can expect a potential return of 1352.7% based on the average DRIO price forecast.
Analyzing the DRIO fundamentals
According to DarioHealth Corp [NASDAQ:DRIO], the company’s sales were 23.05M for trailing twelve months, which represents an 111.00% jump. Gross Profit Margin for this corporation currently stands at 0.4% with Operating Profit Margin at -2.58%, Pretax Profit Margin comes in at -0.97%, and Net Profit Margin reading is -1.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.53 and Total Capital is -0.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6789 points at the first support level, and at 0.6178 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7923, and for the 2nd resistance point, it is at 0.8446.
Ratios To Look Out For
It is important to note that DarioHealth Corp [NASDAQ:DRIO] has a current ratio of 1.57. In addition, the Quick Ratio stands at 1.32 and the Cash Ratio stands at 0.82. Considering the valuation of this stock, the price to sales ratio is 1.09, the price to book ratio is 0.40.
Transactions by insiders
Recent insider trading involved Nelson Steven Charles, Chief Commercial Officer, that happened on Nov 12 ’24 when 5000.0 shares were purchased. Chief Commercial Officer, Nelson Steven Charles completed a deal on Sep 10 ’24 to buy 5000.0 shares. Meanwhile, Chief Commercial Officer Nelson Steven Charles bought 5000.0 shares on Sep 11 ’24.
